FDA Announces Final Guidance on Cancer Clinical Trial Eligibility Criteria

Summary

The US Food and Drug Administration (FDA) has released a final guidance document outlining new eligibility criteria for cancer clinical trials, which will allow patients with a broader range of performance statuses to participate in trials for investigational cancer treatments.